A number of investment brokers have recently updated their price targets on shares of BioDelivery Sciences International, Inc. (BDSI). According to the latest broker reports outstanding on Monday 9th of May, 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

05/04/2016 – BioDelivery Sciences International, Inc. had its “outperform” rating reiterated by analysts at FBR Capital Markets. They now have a USD 9 price target on the stock.

03/14/2016 – BioDelivery Sciences International, Inc. had its “buy” rating reiterated by analysts at Laidlaw. They now have a USD 11 price target on the stock.

03/11/2016 – BioDelivery Sciences International, Inc. had its “buy” rating reiterated by analysts at Roth Capital. They now have a USD 9 price target on the stock.

03/11/2016 – BioDelivery Sciences International, Inc. had its “overweight” rating reiterated by analysts at Piper Jaffray.

12/22/2015 – BioDelivery Sciences International, Inc. had its “buy” rating reiterated by analysts at Cantor Fitzgerald. They now have a USD 14 price target on the stock.

10/27/2015 – BioDelivery Sciences International, Inc. had its “neutral” rating reiterated by analysts at Janney Montgomery Scott. They now have a USD 7 price target on the stock.

09/18/2015 – BioDelivery Sciences International, Inc. had its “buy” rating reiterated by analysts at William Blair. They now have a USD 17 price target on the stock.

05/13/2015 – BioDelivery Sciences International, Inc. was downgraded to “sell” by analysts at Zacks.

12/30/2014 – BioDelivery Sciences International, Inc. had its “buy” rating reiterated by analysts at Summer Street. They now have a USD 28 price target on the stock.

07/08/2014 – BioDelivery Sciences International, Inc. had its “buy” rating reiterated by analysts at Ladenburg Thalmann. They now have a USD 21 price target on the stock.

05/31/2014 – BioDelivery Sciences International, Inc. was downgraded to “sell” by analysts at TheStreet.

05/30/2014 – BioDelivery Sciences International, Inc. was downgraded to “sell” by analysts at ING.

01/25/2014 – BioDelivery Sciences International, Inc. had its “market outperform” rating reiterated by analysts at JMP Securities. They now have a USD 12 price target on the stock.

The share price of BioDelivery Sciences International, Inc. (BDSI) was down -14.81% during the last day of trading, with a day high of 2.66. 1771244 shares were traded during the last session.

The stock’s 50 day moving average is 3.33 and its 200 day moving average is 4.32. The stock’s market capitalization is 121.13M. BioDelivery Sciences International, Inc. has a 52-week low of 2.29 and a 52-week high of 9.91.

View other investors thoughts on BioDelivery Sciences International, Inc. with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.